Abstract
Background
This randomized, double-blind study compared the efficacy of Helicobacter pylori eradication against prokinetics in H. pylori-infected functional dyspepsia patients.
Methods
Patients with moderately severe or severe dyspepsia fulfilling the Rome II criteria were randomized to either H. pylori eradication for 1 week and 6 weeks of placebo prokinetics or 6 weeks of prokinetics and placebo H. pylori eradication in the first week. Symptoms were assessed at baseline and at 6 and 12 months using the Glasgow Dyspepsia Severity Score (GDSS). Global response to treatment was assessed at 12 months.
Results
Altogether 130 patients were enrolled (H. pylori eradication, 71; prokinetics, 59). The mean baseline GDSS was 9.3 for the H. pylori eradication group and 8.9 for the prokinetic group. At 6 months, the score was 3.6 and 4.1, respectively, and it remained at 3.5 and 3.8, respectively, at 12 months. With H. pylori eradication, 31.0% had complete symptom resolution (GDSS 0 or 1) at 12 months compared with 23.7% with prokinetics (a nonsignificant difference). At 12 months, global symptomatic improvement was seen in 62.0% of the H. pylori eradication group compared with 67.8% of the prokinetics group.
Conclusions
Both H. pylori eradication and prokinetic therapy resulted in symptom improvement in two-thirds of dyspeptic patients at 1 year. More patients tended to achieve complete symptom relief with H. pylori eradication.
Similar content being viewed by others
References
L Agreus (2002) ArticleTitleNatural history of dyspepsia Gut 50 IssueIDSuppl IV iv2–9 10.1136/gut.50.suppl_4.iv2 Occurrence Handle10.1136/gut.50.suppl_4.iv2 Occurrence Handle11953337
N Talley M Silverstein L Agreus O Nyren A Sonnenberg G Holtmann (1998) ArticleTitleAGA technical review: evaluation of dyspepsia Gastroenterology 114 582–95 10.1016/S0016-5085(98)70542-6 Occurrence Handle10.1016/S0016-5085(98)70542-6 Occurrence Handle1:STN:280:DyaK1c7ls1Kltg%3D%3D Occurrence Handle9496950
NJ Talley V Stanghellini RC Heading KL Koch JR Malagelada GNJ Tytgat (1999) ArticleTitleFunctional gastroduodenal disorders Gut 45 IssueIDSuppl II 37–42
RS Fisher HP Parkman (1998) ArticleTitleManagement of non-ulcer dyspepsia N Eng J Med 339 1376–81 10.1056/NEJM199811053391907 Occurrence Handle10.1056/NEJM199811053391907 Occurrence Handle1:STN:280:DyaK1M%2Fgs1Kjsg%3D%3D
D Armstrong (1996) ArticleTitleHelicobacter pylori infection and dyspepsia Scand J Gastroenterol 31 IssueIDSuppl II 38–47 Occurrence Handle10.3109/00365529609094532
A Minocha S Mokshagundam SH Gallo PS Rahal (1994) ArticleTitleAlterations in upper gastrointestinal motility in Helicobacter pylori-positive non-ulcer dyspepsia Am J Gastroenterol 89 1797–800 Occurrence Handle1:STN:280:DyaK2M%2FivFWrsA%3D%3D Occurrence Handle7942670
H Miyaji T Azuma S Ito Y Abe H Ono H Suto et al. (1999) ArticleTitleThe effect of Helicobacter pylori eradication therapy on gastric antral myoelectrical activity and gastric emptying in patients with non-ulcer dyspepsia Aliment Pharmacol Ther 13 1473–80 10.1046/j.1365-2036.1999.00634.x Occurrence Handle10.1046/j.1365-2036.1999.00634.x Occurrence Handle1:STN:280:DC%2BD3c%2FjvF2luw%3D%3D Occurrence Handle10571604
Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2005 Jan 25;(1):CD002096
Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2004 Oct 18;(4):CD001960
EM El-Omar S Banerjee A Wirz KE McColl (1996) ArticleTitleThe Glasgow Dyspepsia Severity Score—a tool for the global measurement of dyspepsia Eur J Gastroenterol Hepatol 8 967–71 Occurrence Handle10.1097/00042737-199610000-00006 Occurrence Handle1:STN:280:DyaK2s%2FosVaitA%3D%3D Occurrence Handle8930560
K McColl L Murray E El-Omar A Dickson A El-Nujumi A Wirz et al. (1998) ArticleTitleSymptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia N Engl J Med 339 1869–74 10.1056/NEJM199812243392601 Occurrence Handle10.1056/NEJM199812243392601 Occurrence Handle1:STN:280:DyaK1M%2FmslWmsg%3D%3D Occurrence Handle9862941
S Bruley des Varannes JF Flejou R Colin M Zaim A Meunier C Bidaut-Mazel (2001) ArticleTitleThere are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia Aliment Pharmacol Ther 15 1177–85 10.1046/j.1365-2036.2001.01014.x Occurrence Handle10.1046/j.1365-2036.2001.01014.x Occurrence Handle1:STN:280:DC%2BD3MvktVOntA%3D%3D Occurrence Handle11472320
P Malfertheiner J Mossner W Fischbach P Layer A Leodolter M Stolte et al. (2003) ArticleTitleHelicobacter pylori eradication is beneficial in the treatment of functional dyspepsia Aliment Pharmacol Ther 18 615–25 10.1046/j.1365-2036.2003.01695.x Occurrence Handle10.1046/j.1365-2036.2003.01695.x Occurrence Handle1:CAS:528:DC%2BD3sXos1Clu7k%3D Occurrence Handle12969088
NJ Talley J Janssens K Lauritsen I Racz E Bolling-Sternevald (1999) ArticleTitleEradication of Helicobacter pylori in functional dyspepsia: randomized double blind placebo controlled trial with 12 months follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group BMJ 318 833–7 Occurrence Handle1:CAS:528:DyaK1MXisVaht7s%3D Occurrence Handle10092259
AL Blum NJ Talley C O’Morain SV van Zanten J Labenz M Stolte et al. (1998) ArticleTitleLack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group N Engl J Med 339 1875–81 10.1056/NEJM199812243392602 Occurrence Handle10.1056/NEJM199812243392602 Occurrence Handle1:STN:280:DyaK1M%2FmslWmsw%3D%3D Occurrence Handle9862942
P Sawant HS Das N Desai S Kalokhe S Patil (2004) ArticleTitleComparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia J Assoc Physicians India 52 626–8 Occurrence Handle15847356
DN Amarapurkar P Rane (2004) ArticleTitleRandomised, double-blind, comparative study to evaluate the efficacy and safety of Ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia J Indian Med Assoc 102 735–7 Occurrence Handle15871365
NJ Talley N Vakil ED Ballard Suffix2nd MB Fennerty (1999) ArticleTitleAbsence of benefit of eradicating Helicobacter pylori in patients with non-ulcer dyspepsia N Engl J Med 341 1106–11 10.1056/NEJM199910073411502 Occurrence Handle10.1056/NEJM199910073411502 Occurrence Handle1:STN:280:DyaK1Mvis1Grtg%3D%3D Occurrence Handle10511608
PI Hsu KH Lai HH Tseng GH Lo CC Lo CK Lin et al. (2001) ArticleTitleEradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia Aliment Pharmacol Ther 15 195–201 10.1046/j.1365-2036.2001.00903.x Occurrence Handle10.1046/j.1365-2036.2001.00903.x Occurrence Handle1:STN:280:DC%2BD3M7isF2guw%3D%3D Occurrence Handle11148437
NJ Talley K Lauritsen (2002) ArticleTitleThe potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies Gut 50 IssueIDSuppl IV 36–41
A Raghunath AP Hungin D Wooff S Childs (2003) ArticleTitlePrevalence of Helicobacter pylori in patients with gastroesophageal reflux disease: systematic review BMJ 326 737 10.1136/bmj.326.7392.737 Occurrence Handle10.1136/bmj.326.7392.737 Occurrence Handle12676842
L Laine J Sung (2002) ArticleTitleEffect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies Am J Gastroenterol 97 2992–7 10.1111/j.1572-0241.2002.07116.x Occurrence Handle10.1111/j.1572-0241.2002.07116.x Occurrence Handle12492181
D McNamara C O’Morain (1999) ArticleTitleGastroesophageal reflux disease and Helicobacter pylori: an intricate relation Gut 45 IssueIDSuppl I 13–7 Occurrence Handle10.1136/gut.45.2008.i13
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ang, T., Fock, K., Teo, E. et al. Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study. J Gastroenterol 41, 647–653 (2006). https://doi.org/10.1007/s00535-006-1818-x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00535-006-1818-x